Company attributes
Other attributes
Commence Bio is a therapeutics company that is developing methods to enhance the anti-inflammatory properties of stem cells. The company aims to apply these methods in various inflammation-related disorders that include rheumatoid arthritis, by creating cellular therapeutics with predictable behaviors.
The company's technology is used to change adult, allogeneic mesenchymal stem cells into powerful immunomodulators that migrate to the sites of immune dysfunction through a multi-pronged effect and re-awakening the body's innate and adaptive immune responses, allowing patients to get treatments for cancer and inflammatory diseases by rebooting the immune systems of patients with cell therapies.
Commence Bio has the vision that cancer and inflammatory diseases can be treated by rebooting patients' immune systems with a new class of medicinal stem cells: MSC1 & MSC2. Using its proprietary Stimulated Toll-like Receptor Technology [STaRT™], adult, allogeneic mesenchymal stem cells [MSCs] are transformed into powerful immunomodulators that migrate to the sites of dysfunction and. through a multi-pronged effect, reboot an appropriate immune response.
